- Home
- MBIN vs BCRX Comparison
MBIN vs BCRX Comparison
Compare MBIN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBIN | BCRX |
|---|---|---|
| Founded | 1990 | 1986 |
| Country | United States | United States |
| Employees | 735 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | MBIN | BCRX |
|---|---|---|
| Price | $54.87 | $8.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $43.67 | $20.82 |
| AVG Volume (30 Days) | 143.9K | ★ 3.8M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $31.76 | N/A |
| Revenue Next Year | $3.73 | $12.55 |
| P/E Ratio | $12.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.20 | $6.00 |
| 52 Week High | $56.87 | $11.22 |
Technical Indicators
Market Signals| Indicator | MBIN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 73.49 | 43.35 |
| Support Level | $45.39 | $8.80 |
| Resistance Level | N/A | $9.31 |
| Average True Range (ATR) | 1.76 | 0.33 |
| MACD | 0.79 | -0.08 |
| Stochastic Oscillator | 89.97 | 15.53 |
Price Performance
Historical ComparisonAbout MBIN Merchants Bancorp
Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.